Viewing Study NCT02403193

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:16 AM
Ignite Modification Date: 2026-02-24 @ 11:01 AM
Study NCT ID: NCT02403193
Status: COMPLETED
Last Update Posted: 2022-01-12
First Post: 2015-03-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Trial of PBF-509 and PDR001 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Sponsor: Palobiofarma SL
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Cancer (NSCLC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Adenosine A2a receptor antagonist View
None NSCLC View
None PBF-509 View
None Immunotherapy View
None adenosine View
None PDR001 View
None immune checkpoint inhibitors View
None Programmed Death-1 (PD-1) receptor View
None Adenosine A2a receptor (A2AR) View